MA
Maxele Advisors Portfolio holdings
AUM
$143M
This Fund
S&P 500
This Quarter
Est. Return
+0.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
101.91%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
97
New
97
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.2
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NASDAQ-100 Technology Index Fund
QTEC
|
+$6.04M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.1M |
| 3 |
NVIDIA
NVDA
|
+$4.84M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$3.96M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$3.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.06% |
| 2 | Technology | 9.67% |
| 3 | Healthcare | 4.54% |
| 4 | Consumer Staples | 2.93% |
| 5 | Consumer Discretionary | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Oracle
ORCL
$394B
| $313K | 0.3% |
+1,876
| New | +$333K |
2024 Q4
0 quarters
|
|
77
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $300K | 0.29% |
+2,576
| New | +$300K |
2024 Q4
0 quarters
|
|
78
Morgan Stanley
MS
$285B
| $286K | 0.27% |
+2,275
| New | +$280K |
2024 Q4
0 quarters
|
|
79
Vanguard Morningstar Growth ETF
VUG
$232B
| $280K | 0.27% |
+4,098
| New | +$275K |
2022 Q3
9 quarters
|
|
80
Vanguard Short-Term Bond ETF
BSV
$45.4B
| $278K | 0.27% |
+3,600
| New | +$279K |
2021 Q4
12 quarters
|
|
81
Honeywell
HON
$66.1B
| $271K | 0.26% |
+1,273
| New | +$265K |
2021 Q4
12 quarters
|
|
82
iShares US Healthcare ETF
IYH
$4.11B
| $264K | 0.25% |
+4,525
| New | +$280K |
2021 Q4
12 quarters
|
|
83
Commerce Bancshares
CBSH
$7.79B
| $264K | 0.25% |
+4,442
| New | +$268K |
2024 Q4
0 quarters
|
|
84
Vanguard Short-Term Treasury ETF
VGSH
$35.1B
| $257K | 0.25% |
+4,425
| New | +$258K |
2021 Q4
12 quarters
|
|
85
Broadcom
AVGO
$1.65T
| $253K | 0.24% |
+1,091
| New | +$202K |
2024 Q4
0 quarters
|
|
86
Cisco
CSCO
$447B
| $237K | 0.23% |
+4,001
| New | +$229K |
2024 Q4
0 quarters
|
|
87
Altria Group
MO
$122B
| $235K | 0.22% |
+4,502
| New | +$240K |
2024 Q4
0 quarters
|
|
88
Fidelity MSCI Real Estate Index ETF
FREL
$1.38B
| $233K | 0.22% |
+8,621
| New | +$247K |
2024 Q4
0 quarters
|
|
89
Vanguard FTSE Developed Markets ETF
VEA
$227B
| $226K | 0.22% |
+4,730
| New | +$238K |
2024 Q4
0 quarters
|
|
90
Philip Morris
PM
$319B
| $223K | 0.21% |
+1,856
| New | +$234K |
2024 Q4
0 quarters
|
|
91
Invesco S&P 500 Equal Weight ETF
RSP
$96.7B
| $218K | 0.21% |
+1,245
| New | +$225K |
2024 Q4
0 quarters
|
|
92
Johnson & Johnson
JNJ
$609B
| $216K | 0.21% |
+1,491
| New | +$231K |
2021 Q4
12 quarters
|
|
93
Elevance Health
ELV
$92.3B
| $214K | 0.2% |
+580
| New | +$243K |
2021 Q4
12 quarters
|
|
94
Mastercard
MA
$527B
| $213K | 0.2% |
+405
| New | +$210K |
2024 Q4
0 quarters
|
|
95
iShares 0-5 Year TIPS Bond ETF
STIP
$16.5B
| $213K | 0.2% |
+2,118
| New | +$213K |
2022 Q1
11 quarters
|
|
96
Walt Disney
DIS
$187B
| $207K | 0.2% |
+1,863
| New | +$196K |
2024 Q4
0 quarters
|
|
97
Pfizer
PFE
$167B
| $205K | 0.2% |
+7,714
| New | +$209K |
2021 Q4
12 quarters
|
|
Similar funds
VAM
GC
SL
CC
MC
CP
SAM
MF
Maxele Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Maxele Advisors held 97 positions worth $105M. Its ten largest holdings account for 38% of the portfolio.
Maxele Advisors deployed $107M of net new capital in Q4 2024, opening 97 new positions. Its largest new stake was First Trust NASDAQ-100 Technology Index Fund: 31,052 shares worth $5.85M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, followed by Technology and Healthcare.
- Maxele Advisors's largest Q4 2024 buy was First Trust NASDAQ-100 Technology Index Fund: 31,052 shares worth $5.85M.
- Maxele Advisors's ten largest holdings make up 38% of its $105M portfolio in Q4 2024.
- Maxele Advisors opened 97 new positions and closed 0 in Q4 2024.
Based on Maxele Advisors's 13F filing for Q4 2024, filed 1 Dec 2025.